Meetings

Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH) – a rare, aggressive hyperinflammatory condition – who were treated with the first-in-class monoclonal antibody, ELA026, experienced a 100% response rate and an improved survival rate at two months, according to researchers from The University of Texas MD Anderson Cancer Center.

Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with the American Association for Cancer Research (AACR), hosts the 47^th annual San Antonio Breast Cancer Symposium on Dec. 10-13 in downtown San Antonio. Owned and initiated by Mays Cancer Center, the San Antonio Breast Cancer Symposium is the world’s largest breast cancer research conference where more than 11,000 clinicians, researchers, and patient advocates from more than 102 countries are expected to attend.

The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Investigating the Genetic and Biological Mechanisms That Predispose to Early-Onset Psychotic Illnesses” on Tuesday, December 10, 2024, at 2:00 pm ET.  The presenter, Catherine Astrid Brownstein, Ph.D., M.P.H., is an Assistant Professor in Pediatrics at Harvard Medical School and a Research Associate in the Division of Genetics and Genomics at Boston Children's Hospital. As the Scientific Director for the Manton Center for Orphan Disease Research Gene Discovery Core, Dr. Brownstein has been instrumental in the elucidation of several new disease genes for conditions such as intellectual disability, autism, SIDS, and very early onset psychosis. The host, Jeffrey Borenstein, M.D., is President & CEO of the Brain & Behavior Research Foundation and host of the Emmy® nominated television series Healthy Minds.

Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression to multiple myeloma, a type of rare, incurable blood cancer affecting the bone marrow.

CAMBRIDGE, Mass., Dec 5, 2024 --- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced that it has successfully closed the highly anticipated Pharma.AI week webinar series, with over 500 attendees from 63 countries all over the world, witnessing the release of reinforced generative AI platforms, and the highlights are listed below:

We invite you to register for the 2025 AAAS Annual Meeting from February 13-15, which will be in-person only in Boston, Mass. Eligible journalists, public information officers, and journalism professors and students will be approved with free access. View the schedule.

The 66th Annual Meeting & Exposition of the American Society of Hematology (ASH) will take place in San Diego, Calif. and online Dec. 7-10. See below for oral presentations by Fred Hutch experts.

Investigators from the Mass General Brigham healthcare system will present research discoveries and outcomes from clinical trials at the 2024 American Society of Hematology (ASH) Annual Meeting, held December 7-10, 2024, in San Diego.

ESMO Immuno-Oncology Congress 2024 will take place in Geneva, Switzerland from 11-13 December.